Acasti Pharma Inc

Acasti Pharma Inc

Company profile

About

Acasti Pharma (NASDAQ:ACST) is a biopharmaceutical company dedicated to improving the treatment of rare and orphan diseases. Traded under the symbol ACST on NASDAQ, the company focuses on developing and commercializing innovative pharmaceutical therapies. Acasti leverages its proprietary technologies to tackle medical challenges, with a robust pipeline of products in various stages of development. The company's objectives revolve around advancing its clinical programs, securing regulatory approvals, and exploring strategic partnerships. Acasti aims to make a significant impact in the realm of healthcare by providing effective solutions that address unmet medical needs and enhance the lives of patients worldwide.

Snapshot

-Year founded

0Employees

-Head office

Loading Map...

Global footprint

Operations

All Locations

Products and/or services of Acasti Pharma Inc

The lead project focuses on creating a prescription-grade omega-3 phospholipid therapy designed to treat severe hypertriglyceridemia with better absorption compared to existing omega-3 therapies.
Efforts are underway to develop a lipid modulation therapy focusing on controlling lipid metabolism disorders, targeting cardiovascular health improvements.
Research aims to pioneer a medical treatment that harnesses omega-3 based molecules, designed to improve the bioavailability of heart-health supplements.
Development is centered on novel drug compounds aimed to offer unique profiles for chronic cardiovascular conditions.
R&D initiatives are directed towards creating a platform for proprietary formulation technologies to enhance efficacy and patient compliance.
Work includes strategic collaborations and partnerships to expand and accelerate the development pipeline for novel cardiovascular therapies.